Objective Lung cancer dysregulations impart oxidative stress which results in important
metabolic products in the form of volatile organic compounds (VOCs) in exhaled breath. The …

The aim of the present study was to investigate the ability of breath analysis to distinguish
lung cancer (LC) patients from patients with other respiratory diseases and healthy people …

Study objectives To evaluate volatile organic compounds (VOCs) in the breath as tumor
markers in lung cancer. Alkanes and monomethylated alkanes are oxidative stress products …

Background Lung cancer remains the leading cause of cancer deaths accounting for almost
25% of all cancer deaths. Breath-based volatile organic compounds (VOCs) have been …

Simple Summary Human-exhaled volatile organic compounds (VOCs) can be altered by
lung cancer and become identifiable biomarkers. We used selected ion flow tube mass …

Early detection of lung cancer is a crucial factor for increasing its survival rates among the
detected patients. The presence of carbonyl volatile organic compounds (VOCs) in exhaled …

Objective Several volatile carbonyl compounds in exhaled breath have been identified as
cancer-specific markers. The potential for these markers to serve as a screening test for lung …

Background Breath analysis is a promising noninvasive technique that offers a wide range
of opportunities to facilitate early diagnosis of lung cancer (LC). Method Exhaled breath …

Background: Volatile organic compounds (VOCs) biomarkers in breath provide a novel,
noninvasive and quick approach to diagnosis lung cancer. The aim of the proposed study …

Background: Normal metabolism generates several volatile organic compounds (VOCs) that
are excreted in the breath (eg alkanes). In patients with lung cancer, induction of high-risk …